GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹144 Cr | ₹111 Cr | ₹108 Cr | ₹125 Cr | ₹159 Cr |
What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹144 Cr |
| Mar2025 | ₹111 Cr |
| Mar2024 | ₹108 Cr |
| Mar2023 | ₹125 Cr |
| Mar2022 | ₹159 Cr |
How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹144 Cr | 29.59 | |
| Mar2025 | ₹111 Cr | 2.80 | |
| Mar2024 | ₹108 Cr | -14.10 | |
| Mar2023 | ₹125 Cr | -21.01 | |
| Mar2022 | ₹159 Cr | - | |
Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹50,118.7 Cr | -3.1% | 14.7% | 4.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -3.1% |
14.7% |
4.7% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses